Keywords: strong, hits, ares-serono, european, growth, geneva, switzerland-based
Strong $ Hits Ares-Serono's European Growth
Article | 16 January 1998
Geneva, Switzerland-based Ares-Serono reports unaudited net sales of$864 million for 1997, a rise of 7.3%. Excluding exchange rates, the company says sales ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
